Related Experiment Video
Updated: Sep 17, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagy and oxidative stress in solid tumors: Mechanisms and therapeutic opportunities
María Carretero-Fernández1, Antonio José Cabrera-Serrano2, José Manuel Sánchez-Maldonado2
1Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada 18016, Spain; Instituto de Investigación Biosanitaria IBs.Granada, Granada 18012, Spain; Medical Oncology Unit, University Hospital of Jaén, Jaén 23007, Spain.
Abstract:
Cancer remains a leading cause of mortality worldwide, with solid tumors representing most cases. Autophagy and oxidative stress are two interconnected cellular mechanisms that influence tumor initiation, therapeutic response and disease progression. Autophagy plays a context-dependent role, functioning as a tumor suppressor by eliminating damaged organelles in early stages, while later supporting tumor survival under metabolic and therapeutic stress. Similarly, oxidative stress, characterized by an imbalance in reactive oxygen species (ROS), can drive tumorigenesis by promoting genomic instability and resistance to therapy but can also induce apoptosis in cancer cells. The crosstalk between autophagy and oxidative stress plays a pivotal role in shaping the tumor microenvironment, affecting immune evasion, drug resistance, and metabolic adaptation. Targeting these processes through pharmacological modulation presents both challenges and opportunities in cancer therapy. While autophagy inhibition can enhance chemotherapy efficacy by preventing tumor cell survival mechanisms, excessive oxidative stress induction may lead to cellular damage and systemic toxicity. This review explores the complex interplay between autophagy and oxidative stress in solid tumors, emphasizing their implications for cancer progression and treatment strategies. By understanding these mechanisms, novel therapeutic approaches, including combination therapies and precision medicine strategies, may be developed to improve patient outcomes.
Insights
Autophagy and oxidative stress are key cellular processes in solid tumors. Understanding their complex interplay can reveal new cancer treatment strategies and improve patient outcomes.
Area of Science:
- Oncology
- Cellular Biology
- Biochemistry
Background:
- Cancer is a major global health issue, with solid tumors being the most common type.
- Autophagy and oxidative stress are critical cellular mechanisms influencing cancer development and response to treatment.
- These processes have dual roles, acting as tumor suppressors or promoters depending on the context.
Purpose of the Study:
- To review the intricate relationship between autophagy and oxidative stress in solid tumors.
- To highlight the implications of this crosstalk for tumor progression and therapeutic strategies.
- To explore potential novel therapeutic approaches targeting these pathways.
Main Methods:
- Literature review of studies on autophagy, oxidative stress, and solid tumors.
- Analysis of the interconnected roles of these mechanisms in tumorigenesis and treatment resistance.
- Examination of pharmacological targeting strategies and their associated challenges.
Main Results:
- Autophagy and oxidative stress (ROS imbalance) have context-dependent roles in cancer, influencing initiation, progression, and survival.
- Their crosstalk impacts the tumor microenvironment, affecting immune evasion, drug resistance, and metabolic adaptation.
- Targeting these pathways offers therapeutic opportunities but also presents challenges like potential systemic toxicity.
Conclusions:
- The interplay between autophagy and oxidative stress is crucial in solid tumors, impacting various aspects of cancer biology.
- Understanding these mechanisms is vital for developing innovative cancer therapies, including combination and precision medicine approaches.
- Further research into modulating autophagy and oxidative stress could lead to improved patient outcomes in cancer treatment.
Related Concept Videos
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

